Anandamide

Anandamide is a lipid of Fatty Acyls (FA) class. Anandamide is associated with abnormalities such as Dehydration. The involved functions are known as Process, Phenomenon, Phosphorylation, Catabolic Process and Gene Expression. Anandamide often locates in Nuchal region, Microglial and Hepatic. The associated genes with Anandamide are SGPL1 gene, SPTLC1 gene, RPSA gene, KDSR gene and SMPD1 gene. The related lipids are Sphingolipids, Lipopolysaccharides, Lysophospholipids, LYSO-PC and lysophosphatidylethanolamine.

Cross Reference

Introduction

To understand associated biological information of Anandamide, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Anandamide?

Anandamide is suspected in Dehydration and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Anandamide

MeSH term MeSH ID Detail
Acute Pain D059787 3 associated lipids
Vascular System Injuries D057772 2 associated lipids
Orthostatic Intolerance D054971 1 associated lipids
Headache Disorders, Secondary D051271 1 associated lipids
Overweight D050177 11 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Sleep Disorders, Intrinsic D020919 1 associated lipids
Somatosensory Disorders D020886 1 associated lipids
Parkinsonian Disorders D020734 20 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Amnesia, Anterograde D020324 2 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Sleep Apnea, Obstructive D020181 9 associated lipids
Substance-Related Disorders D019966 2 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Endotoxemia D019446 27 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Impotence, Vasculogenic D018783 4 associated lipids
Ventricular Dysfunction, Left D018487 33 associated lipids
Cholangiocarcinoma D018281 7 associated lipids
Cardiovirus Infections D018188 3 associated lipids
Alveolar Bone Loss D016301 10 associated lipids
Ocular Hypotension D015814 2 associated lipids
Weight Gain D015430 101 associated lipids
Reperfusion Injury D015427 65 associated lipids
Ventricular Fibrillation D014693 16 associated lipids
Urinary Incontinence D014549 4 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Stomach Ulcer D013276 75 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Sleep Deprivation D012892 5 associated lipids
Shock, Septic D012772 11 associated lipids
Seizures D012640 87 associated lipids
Schistosomiasis japonica D012554 3 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Pregnancy, Ectopic D011271 5 associated lipids
Picornaviridae Infections D010850 4 associated lipids
Peripheral Nervous System Diseases D010523 33 associated lipids
Peptic Ulcer D010437 19 associated lipids
Parkinson Disease, Secondary D010302 17 associated lipids
Pain D010146 64 associated lipids
Obesity D009765 29 associated lipids
Neuroblastoma D009447 66 associated lipids
Neuralgia D009437 28 associated lipids
Nervous System Diseases D009422 37 associated lipids
Nerve Degeneration D009410 53 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Neoplasms D009369 13 associated lipids
Neoplasm Invasiveness D009361 23 associated lipids
Mycoses D009181 18 associated lipids
Muscle Spasticity D009128 5 associated lipids
Multiple Sclerosis D009103 13 associated lipids
Morphine Dependence D009021 9 associated lipids
Migraine Disorders D008881 11 associated lipids
Memory Disorders D008569 33 associated lipids
Melanoma D008545 69 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Learning Disorders D007859 11 associated lipids
Intestinal Pseudo-Obstruction D007418 5 associated lipids
Insulin Resistance D007333 99 associated lipids
Inflammation D007249 119 associated lipids
Hypothermia D007035 19 associated lipids
Hypotension D007022 41 associated lipids
Hypertension, Portal D006975 12 associated lipids
Hypertension D006973 115 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Hyperkinesis D006948 11 associated lipids
Hyperinsulinism D006946 27 associated lipids
Hyperemia D006940 25 associated lipids
Hyperalgesia D006930 42 associated lipids
Hepatitis D006505 11 associated lipids
Glioma D005910 112 associated lipids
Fibromyalgia D005356 4 associated lipids
Fever D005334 35 associated lipids
Fatty Liver D005234 48 associated lipids
Epilepsy D004827 35 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Edema D004487 152 associated lipids
Dyskinesia, Drug-Induced D004409 15 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Cough D003371 19 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Colitis D003092 69 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Brain Ischemia D002545 89 associated lipids
Celiac Disease D002446 16 associated lipids
Catalepsy D002375 30 associated lipids
Cardiomyopathy, Dilated D002311 15 associated lipids
Bulimia D002032 3 associated lipids
Bronchial Spasm D001986 18 associated lipids
Breast Neoplasms D001943 24 associated lipids
Brain Edema D001929 20 associated lipids
Brain Damage, Chronic D001925 6 associated lipids
Brain Concussion D001924 5 associated lipids
Bradycardia D001919 13 associated lipids
Body Weight D001835 333 associated lipids
Per page 10 20 50 100 | Total 105

PubChem Associated disorders and diseases

What pathways are associated with Anandamide

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Anandamide?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Anandamide?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Anandamide?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Anandamide?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Anandamide?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Anandamide

Download all related citations
Per page 10 20 50 100 | Total 2222
Authors Title Published Journal PubMed Link
Frazier CJ Key questions of endocannabinoid signalling in the CNS: which, where and when? 2011 J. Physiol. (Lond.) pmid:22001725
Ito T et al. Propofol protects against anandamide-induced injury in human umbilical vein endothelial cells. 2011 Kurume Med J pmid:22027193
Hayase T Differential effects of TRPV1 receptor ligands against nicotine-induced depression-like behaviors. 2011 BMC Pharmacol. pmid:21767384
Sridar C et al. Anandamide oxidation by wild-type and polymorphically expressed CYP2B6 and CYP2D6. 2011 Drug Metab. Dispos. pmid:21289075
Kim HY et al. A synaptogenic amide N-docosahexaenoylethanolamide promotes hippocampal development. 2011 Prostaglandins Other Lipid Mediat. pmid:21810478
Brighton PJ et al. Characterization of the endocannabinoid system, CB(1) receptor signalling and desensitization in human myometrium. 2011 Br. J. Pharmacol. pmid:21486283
Gomes FV et al. Facilitation of CB1 receptor-mediated neurotransmission decreases marble burying behavior in mice. 2011 Prog. Neuropsychopharmacol. Biol. Psychiatry pmid:21111767
Cassano T et al. Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice. 2011 Psychopharmacology (Berl.) pmid:21042794
Justinová Z et al. Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonist. 2011 Addict Biol pmid:21054689
Chiba T et al. A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells. 2011 J. Pharm. Pharmacol. pmid:21492165
Huang L et al. Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptor. 2011 Lab. Invest. pmid:21464819
Dean C Endocannabinoid modulation of sympathetic and cardiovascular responses to acute stress in the periaqueductal gray of the rat. 2011 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:21228344
Engel MA et al. Inhibitory CB1 and activating/desensitizing TRPV1-mediated cannabinoid actions on CGRP release in rodent skin. 2011 Neuropeptides pmid:21514666
Latek D et al. Modeling of ligand binding to G protein coupled receptors: cannabinoid CB1, CB2 and adrenergic β 2 AR. 2011 J Mol Model pmid:21365223
Signorello MG et al. The anandamide effect on NO/cGMP pathway in human platelets. 2011 J. Cell. Biochem. pmid:21328466
Greco R et al. Effects of anandamide in migraine: data from an animal model. 2011 J Headache Pain pmid:21331757
Johannesson M et al. Cloning, purification and characterization of non-human primate 12/15-lipoxygenases. 2010 Feb-Mar Prostaglandins Leukot. Essent. Fatty Acids pmid:20106647
Buznikov GA et al. A putative 'pre-nervous' endocannabinoid system in early echinoderm development. 2010 Dev. Neurosci. pmid:19907129
Kaczocha M et al. Lipid droplets are novel sites of N-acylethanolamine inactivation by fatty acid amide hydrolase-2. 2010 J. Biol. Chem. pmid:19926788
Aquila S et al. Human sperm anatomy: ultrastructural localization of the cannabinoid1 receptor and a potential role of anandamide in sperm survival and acrosome reaction. 2010 Anat Rec (Hoboken) pmid:19938110
Wiley JL and Burston JJ Chronic Delta9-tetrahydrocannabinol during adolescence increases sensitivity to subsequent cannabinoid effects in delayed nonmatch-to-position in rats. 2010 Pharmacol. Biochem. Behav. pmid:19941884
Piccinetti CC et al. Anandamide and AM251, via water, modulate food intake at central and peripheral level in fish. 2010 Gen. Comp. Endocrinol. pmid:19800340
Banni S and Di Marzo V Effect of dietary fat on endocannabinoids and related mediators: consequences on energy homeostasis, inflammation and mood. 2010 Mol Nutr Food Res pmid:20013888
Amoako AA et al. Quantitative analysis of anandamide and related acylethanolamides in human seminal plasma by ultra performance liquid chromatography tandem mass spectrometry. 2010 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:21056015
Godlewski G et al. Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects. 2010 Chem. Biol. pmid:21095576
Di Marzo V Anandamide serves two masters in the brain. 2010 Nat. Neurosci. pmid:21102567
Zakrzeska A et al. A cannabinoid receptor, sensitive to O-1918, is involved in the delayed hypotension induced by anandamide in anaesthetized rats. 2010 Br. J. Pharmacol. pmid:20105178
Rajesh M et al. Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells. 2010 Br. J. Pharmacol. pmid:20590572
Wheal AJ et al. Vasorelaxation to N-oleoylethanolamine in rat isolated arteries: mechanisms of action and modulation via cyclooxygenase activity. 2010 Br. J. Pharmacol. pmid:20590573
Gutierrez-Lopez MD et al. Involvement of 2-arachidonoyl glycerol in the increased consumption of and preference for ethanol of mice treated with neurotoxic doses of methamphetamine. 2010 Br. J. Pharmacol. pmid:20590579
Soneji ND et al. Effects of cannabinoids on capsaicin receptor activity following exposure of primary sensory neurons to inflammatory mediators. 2010 Life Sci. pmid:20598325
Patsos HA et al. The endogenous cannabinoid, anandamide, induces COX-2-dependent cell death in apoptosis-resistant colon cancer cells. 2010 Int. J. Oncol. pmid:20514410
Maccarrone M et al. Intracellular trafficking of anandamide: new concepts for signaling. 2010 Trends Biochem. Sci. pmid:20570522
Fernandez-Solari J et al. Participation of the endocannabinoid system in lipopolysaccharide-induced inhibition of salivary secretion. 2010 Arch. Oral Biol. pmid:20542488
Bhaskaran MD and Smith BN Cannabinoid-mediated inhibition of recurrent excitatory circuitry in the dentate gyrus in a mouse model of temporal lobe epilepsy. 2010 PLoS ONE pmid:20498848
Muccioli GG et al. The endocannabinoid system links gut microbiota to adipogenesis. 2010 Mol. Syst. Biol. pmid:20664638
Clapper JR et al. Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism. 2010 Nat. Neurosci. pmid:20852626
Jenkin KA et al. Role for cannabinoid receptors in human proximal tubular hypertrophy. 2010 Cell. Physiol. Biochem. pmid:21220919
Yang Q et al. Anandamide induces cell death through lipid rafts in hepatic stellate cells. 2010 J. Gastroenterol. Hepatol. pmid:20059638
Sang N et al. Anandamide potentiation of miniature spontaneous excitatory synaptic transmission is mediated via IP3 pathway. 2010 Neurochem. Int. pmid:20064571
Aquila S et al. Rimonabant (SR141716) induces metabolism and acquisition of fertilizing ability in human sperm. 2010 Br. J. Pharmacol. pmid:20067470
Marczylo TH et al. Anandamide levels in human female reproductive tissues: solid-phase extraction and measurement by ultraperformance liquid chromatography tandem mass spectrometry. 2010 Anal. Biochem. pmid:20026294
Touriño C et al. FAAH deficiency promotes energy storage and enhances the motivation for food. 2010 Int J Obes (Lond) pmid:20029375
Yoshida R et al. Endocannabinoids selectively enhance sweet taste. 2010 Proc. Natl. Acad. Sci. U.S.A. pmid:20080779
Ligresti A et al. Exploiting nanotechnologies and TRPV1 channels to investigate the putative anandamide membrane transporter. 2010 PLoS ONE pmid:20422025
Annuzzi G et al. Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients. 2010 Lipids Health Dis pmid:20426869
Cozzolino R et al. A metabolically stable analogue of anandamide, Met-F-AEA, inhibits human thyroid carcinoma cell lines by activation of apoptosis. 2010 Invest New Drugs pmid:19189054
Barana A et al. Endocannabinoids and cannabinoid analogues block cardiac hKv1.5 channels in a cannabinoid receptor-independent manner. 2010 Cardiovasc. Res. pmid:19689982
Gratzke C et al. Localization and function of cannabinoid receptors in the corpus cavernosum: basis for modulation of nitric oxide synthase nerve activity. 2010 Eur. Urol. pmid:19147270
Prieto D Editorial comment on: localization and function of cannabinoid receptors in the corpus cavernosum: basis for modulation of nitric oxide synthase nerve activity. 2010 Eur. Urol. pmid:19147273